{"log_id": 7010844532972361784, "direction": 0, "words_result_num": 70, "words_result": [{"probability": {"variance": 0.005061, "average": 0.97501, "min": 0.575774}, "location": {"width": 740, "top": 95, "height": 29, "left": 172}, "words": "4.舒芬太尼可以导致肌肉僵直,包括胸壁肌肉的僵直,可以通过缓慢地静脉注射本品加以预防通常在使用低剂量"}, {"probability": {"variance": 0.001185, "average": 0.98338, "min": 0.853281}, "location": {"width": 338, "top": 116, "height": 21, "left": 172}, "words": "时可以奏效),或同时使用苯二氮卓类药物及肌松药"}, {"probability": {"variance": 0.012223, "average": 0.961246, "min": 0.44147}, "location": {"width": 740, "top": 134, "height": 28, "left": 171}, "words": "5.如果术前所用的抗胆碱药物剂量不足,或本品与非迷走神经抑制的肌肉松弛药合并使用时,可能导致心动过缓"}, {"probability": {"variance": 0.006426, "average": 0.9747, "min": 0.647422}, "location": {"width": 271, "top": 154, "height": 20, "left": 172}, "words": "甚至心搏停止,心动过缓可用阿托品治疗"}, {"probability": {"variance": 0.016239, "average": 0.939736, "min": 0.494278}, "location": {"width": 741, "top": 172, "height": 29, "left": 170}, "words": "6.对年状腺功能低下、肺病疾患,肝和或肾功能不全、老年人、肥胖,港精中毒和使用过其他已知对中枢神经系"}, {"probability": {"variance": 0.005701, "average": 0.971251, "min": 0.621299}, "location": {"width": 666, "top": 192, "height": 27, "left": 171}, "words": "统有抑制作用的药物的患者。在使用本品时均需要特别注意。建议对这些患者做较长时间的术后观察"}, {"probability": {"variance": 0.010533, "average": 0.957928, "min": 0.535635}, "location": {"width": 739, "top": 211, "height": 30, "left": 170}, "words": "7.对驾车和操作机器能力的影响,使用本品后,患者不能驾车与操作机械。直到得到医师的允许,病人应该在素"}, {"probability": {"variance": 3e-06, "average": 0.998315, "min": 0.99449}, "location": {"width": 225, "top": 233, "height": 18, "left": 172}, "words": "里受到护理并不能饮用含酒精饮料"}, {"probability": {"variance": 0.00644, "average": 0.963987, "min": 0.540412}, "location": {"width": 742, "top": 251, "height": 28, "left": 170}, "words": "8.药品使用和处理中的特殊注意事项:1)剩余药液应该丢弃。2)使用前应对容器及溶液进行仔细检查。正常溶"}, {"probability": {"variance": 0.00709, "average": 0.948097, "min": 0.656159}, "location": {"width": 346, "top": 269, "height": 22, "left": 171}, "words": "液为清澈、无颗粒、无色状。破损容器内药品应丢弃"}, {"probability": {"variance": 0.014511, "average": 0.913025, "min": 0.690352}, "location": {"width": 93, "top": 275, "height": 15, "left": 547}, "words": "9运动员真用"}, {"probability": {"variance": 0.002714, "average": 0.979166, "min": 0.804742}, "location": {"width": 333, "top": 287, "height": 19, "left": 75}, "words": "【孕妇及哺乳期妇女用药】在孕期和哺乳期间禁用"}, {"probability": {"variance": 0.014566, "average": 0.951995, "min": 0.423267}, "location": {"width": 831, "top": 305, "height": 30, "left": 75}, "words": "【儿童用药】舒芬太尼月于两岁以下儿童的有效性和安全性的资料非常有限用于212岁儿童以枸酸舒芬太尼为主的全芽麻"}, {"probability": {"variance": 0.021774, "average": 0.909253, "min": 0.399251}, "location": {"width": 703, "top": 328, "height": 27, "left": 170}, "words": "醉中用药总量建议为10-12日k体重,如果临床表现镇痛效应降低时,可给子额外的剂量12μg9体重"}, {"probability": {"variance": 0.000256, "average": 0.990558, "min": 0.941976}, "location": {"width": 213, "top": 345, "height": 19, "left": 74}, "words": "【老年用药】详见【用法用量】"}, {"probability": {"variance": 0.00366, "average": 0.978613, "min": 0.631026}, "location": {"width": 834, "top": 363, "height": 28, "left": 74}, "words": "【药物相互作用】1.同时使用已比类制剂,阿片类制剂、镇静剂、神经安定类制剂、酒精及其他麻醉剂或其它对中枢神经系"}, {"probability": {"variance": 0.006948, "average": 0.972917, "min": 0.574203}, "location": {"width": 497, "top": 382, "height": 25, "left": 169}, "words": "统有抑制作用的药物,可能导致本品对呼吸和中枢神经系统抑制作用的加强"}, {"probability": {"variance": 0.008099, "average": 0.967724, "min": 0.484292}, "location": {"width": 574, "top": 403, "height": 24, "left": 168}, "words": "2.同时给予高剂量的本品和高浓度的笑气时可导致血压、心率降低以及心输出量的减少"}, {"probability": {"variance": 0.012859, "average": 0.944373, "min": 0.568363}, "location": {"width": 438, "top": 422, "height": 22, "left": 168}, "words": "3.—般建议麻醉或外科手术前两周,不应该使用单胺氧化酶制剂"}, {"probability": {"variance": 0.026062, "average": 0.930333, "min": 0.37354}, "location": {"width": 739, "top": 439, "height": 30, "left": 168}, "words": "4.本品主细胞色素的同工酶CP3A4谢。临床上尚未观察到两者有相互作用,但实验资料却提示CYP3A4"}, {"probability": {"variance": 0.009711, "average": 0.957211, "min": 0.50092}, "location": {"width": 624, "top": 459, "height": 27, "left": 170}, "words": "抑制剂,如红霉素、酮康唑、伊曲康唑和 ltironavir会抑制舒芬太尼的代谢从而延长呼吸扣制作用"}, {"probability": {"variance": 0.008493, "average": 0.970518, "min": 0.487371}, "location": {"width": 541, "top": 479, "height": 25, "left": 198}, "words": "如果必须与上述药物同时应用,应该对病人进行特殊益,并且应降低本品的剂量"}, {"probability": {"variance": 0.010608, "average": 0.967106, "min": 0.443111}, "location": {"width": 836, "top": 495, "height": 31, "left": 71}, "words": "【药物过量】过量用药可导致药物的药理作用租不良反应同时增大,其临床症状与个体对药物的敏感性有关,主要以呼吸抑制"}, {"probability": {"variance": 0.002532, "average": 0.978522, "min": 0.76645}, "location": {"width": 363, "top": 517, "height": 21, "left": 168}, "words": "为其特征,个别敏感者可表现为呼吸过缓甚至呼吸暂停"}, {"probability": {"variance": 0.015956, "average": 0.937629, "min": 0.473749}, "location": {"width": 707, "top": 534, "height": 29, "left": 197}, "words": "治疗和处理:快氧科辅助呼吸或控制呼吸可用于治疗换气不足和呼吸暂停。特异性拮抗剂,如纳络酮,可用"}, {"probability": {"variance": 0.007838, "average": 0.96404, "min": 0.633833}, "location": {"width": 735, "top": 554, "height": 28, "left": 168}, "words": "于逆转呼吸扣制。然而,这类治疗并不能取代即时的对症治疗措施。因为呼吸抑制的持续时间可能超过拮抗剂的"}, {"probability": {"variance": 0.002403, "average": 0.985242, "min": 0.789708}, "location": {"width": 258, "top": 574, "height": 20, "left": 167}, "words": "作用时间,故可能需要重复给予拮抗剂"}, {"probability": {"variance": 0.006034, "average": 0.962671, "min": 0.631858}, "location": {"width": 689, "top": 592, "height": 29, "left": 213}, "words": "旦发生肌肉僵直,可给子肌肉松弛药或控制呼吸。为了保持体温恒定和维持体液的平衡,应该细致地监护"}, {"probability": {"variance": 0.010393, "average": 0.9647, "min": 0.536633}, "location": {"width": 525, "top": 611, "height": 24, "left": 167}, "words": "患者。由于严重的或长期的低血客量还可导致低血压,可采用适当的扩容来治疗"}, {"probability": {"variance": 0.013921, "average": 0.954179, "min": 0.364976}, "location": {"width": 833, "top": 627, "height": 32, "left": 70}, "words": "【药理毒理】舒芬太尼是一种强效的片类镇痛药,同时也是一种特异性μ一阿片受体激动剂,对μ一受体的亲合力比芬太尼"}, {"probability": {"variance": 0.010245, "average": 0.945884, "min": 0.644233}, "location": {"width": 737, "top": 649, "height": 28, "left": 167}, "words": "( fentanyl强7一10倍。舒芬太尼的镇痛效果比芬太尼强好几倍,而且有良好的血液动力学稳定性,可同时保证足"}, {"probability": {"variance": 0.020228, "average": 0.914009, "min": 0.58178}, "location": {"width": 105, "top": 670, "height": 17, "left": 167}, "words": "够的心册氧供应"}, {"probability": {"variance": 0.000789, "average": 0.991408, "min": 0.813763}, "location": {"width": 707, "top": 687, "height": 28, "left": 195}, "words": "静脉给药后几分钟内就能发挥最大的药效,药理学研究结果中,重要的一方面是心血管的稳定性,脑电图反"}, {"probability": {"variance": 0.016135, "average": 0.952915, "min": 0.371972}, "location": {"width": 738, "top": 705, "height": 29, "left": 165}, "words": "应与太尼类同,同时不存在免疫抑制、溶血或组胺释放等不良反应。就像在其他同片类药物研究中已经发现的"}, {"probability": {"variance": 0.014244, "average": 0.953779, "min": 0.507796}, "location": {"width": 735, "top": 725, "height": 28, "left": 165}, "words": "那样,心动过缓的可能性被解释为其对中枢迷走核的作用。舒芬太尼不能或仅能轻微地抑制由泮库溴铵所致的心"}, {"probability": {"variance": 0.001738, "average": 0.962786, "min": 0.904546}, "location": {"width": 46, "top": 744, "height": 17, "left": 165}, "words": "率增加"}, {"probability": {"variance": 0.013794, "average": 0.948794, "min": 0.473192}, "location": {"width": 709, "top": 763, "height": 28, "left": 194}, "words": "舒芬太足有较宽的安全范围。大鼠的最低度麻醉的半数致死剂量半教有效剂量,(LD/ED)的比率是"}, {"probability": {"variance": 0.018321, "average": 0.935238, "min": 0.407111}, "location": {"width": 738, "top": 784, "height": 27, "left": 165}, "words": "25211,比芬太尼(277)或吗啡695)都高。药物在体内有限的积蓄和迅速的清除使病人能迅速地苏醒镇痛的深"}, {"probability": {"variance": 2.2e-05, "average": 0.99694, "min": 0.980302}, "location": {"width": 362, "top": 803, "height": 22, "left": 163}, "words": "度与剂量有关,并且可以调节到适合于手术的痛觉水平"}, {"probability": {"variance": 0.01045, "average": 0.973938, "min": 0.362964}, "location": {"width": 709, "top": 823, "height": 27, "left": 194}, "words": "根据剂量和静注的速度,舒芬太尼有可能引起肌肉僵直、欣快感、缩瞳和心动过缓所有这些舒芬太尼的作"}, {"probability": {"variance": 0.003177, "average": 0.971201, "min": 0.741495}, "location": {"width": 541, "top": 842, "height": 24, "left": 164}, "words": "用均可通过使用其拮抗剂,如:纳络酮、烯丙吗啡或烯丙左吗喃迅速和完全的逆转"}, {"probability": {"variance": 0.009078, "average": 0.96898, "min": 0.437796}, "location": {"width": 838, "top": 858, "height": 31, "left": 65}, "words": "【药代动力学】通过剂量为2501500微克舒芬太尼的静脉给药后观测血液和血清中舒芬太尼的浓度,其分布相的半衰期分别为"}, {"probability": {"variance": 0.009214, "average": 0.964643, "min": 0.564589}, "location": {"width": 739, "top": 880, "height": 27, "left": 162}, "words": "2.3-45分钟和35-73分钟,平均清涂半衰期为784分钟,变化范围为656-938分钟。在中央室的分布容积为142"}, {"probability": {"variance": 0.010604, "average": 0.964647, "min": 0.363669}, "location": {"width": 739, "top": 898, "height": 29, "left": 161}, "words": "升,其稳态的分布容积为344升。其清除率为914毫升分钟在有限的检测方法下,发现给药剂量为250微克时清"}, {"probability": {"variance": 0.006567, "average": 0.966277, "min": 0.608213}, "location": {"width": 301, "top": 918, "height": 21, "left": 162}, "words": "除半衰期(240分钟)明显的比1500微克时短"}, {"probability": {"variance": 0.011361, "average": 0.960809, "min": 0.445771}, "location": {"width": 709, "top": 936, "height": 29, "left": 191}, "words": "药物的血浆浓度从治疗水平降到亚治疗水平取决于药物分布相的半衰期而不是取决于终太半衰期(给药量为"}, {"probability": {"variance": 0.017001, "average": 0.953411, "min": 0.361723}, "location": {"width": 735, "top": 956, "height": 28, "left": 165}, "words": "250微克时的4,1小时到给药量为500-1500微克后的10-16小时1在研究的剂重范围内,舒芬太尼体现了线性药"}, {"probability": {"variance": 0.000449, "average": 0.983526, "min": 0.938064}, "location": {"width": 106, "top": 976, "height": 17, "left": 162}, "words": "代动力学的特征"}, {"probability": {"variance": 0.0126, "average": 0.958947, "min": 0.417187}, "location": {"width": 710, "top": 994, "height": 28, "left": 190}, "words": "舒芬太尼的生物转化主要在和小肠内进行。在24小时内所给药物的8%被排泄,仅有2%以原形被排泄"}, {"probability": {"variance": 0.001889, "average": 0.974911, "min": 0.825806}, "location": {"width": 244, "top": 1014, "height": 20, "left": 161}, "words": "有92.5%的舒芬太尼与血浆蛋白结合"}, {"probability": {"variance": 0.003799, "average": 0.974518, "min": 0.715953}, "location": {"width": 339, "top": 1032, "height": 19, "left": 74}, "words": "贮】遮光密闭,于室温(10-30℃)下保存"}, {"probability": {"variance": 0.016382, "average": 0.924688, "min": 0.524081}, "location": {"width": 322, "top": 1050, "height": 20, "left": 65}, "words": "包装】玻璃安,1:50μg10支/盒"}, {"probability": {"variance": 1.9e-05, "average": 0.996221, "min": 0.986889}, "location": {"width": 148, "top": 1056, "height": 19, "left": 638}, "words": "【有效期】24个月"}, {"probability": {"variance": 0.030776, "average": 0.900651, "min": 0.35907}, "location": {"width": 225, "top": 1072, "height": 18, "left": 160}, "words": "玻璃安,2ml100ug10支/盒"}, {"probability": {"variance": 0.015708, "average": 0.920548, "min": 0.656774}, "location": {"width": 225, "top": 1091, "height": 20, "left": 159}, "words": "玻璃安瓿,5m:250ug5支/盒"}, {"probability": {"variance": 0.024362, "average": 0.924142, "min": 0.421707}, "location": {"width": 195, "top": 1075, "height": 25, "left": 637}, "words": "【执行标准】YBH0772005"}, {"probability": {"variance": 0.019488, "average": 0.925187, "min": 0.360454}, "location": {"width": 519, "top": 1106, "height": 29, "left": 62}, "words": "【批准文号】1m:50ug国药准字H20054171准许证号:TD2006-004"}, {"probability": {"variance": 0.013331, "average": 0.938528, "min": 0.58097}, "location": {"width": 421, "top": 1129, "height": 24, "left": 159}, "words": "2m:100μg国药准字H20054172准许证号:T02006-0084"}, {"probability": {"variance": 0.011119, "average": 0.947225, "min": 0.54241}, "location": {"width": 422, "top": 1148, "height": 24, "left": 158}, "words": "5m250μg国药准字H20054256准许证号:T02006-0084"}, {"probability": {"variance": 0.000114, "average": 0.994395, "min": 0.950707}, "location": {"width": 352, "top": 1163, "height": 27, "left": 61}, "words": "【生产企业】企业名称:宜昌人福药业有限责任公司"}, {"probability": {"variance": 1e-05, "average": 0.997404, "min": 0.988208}, "location": {"width": 274, "top": 1186, "height": 19, "left": 156}, "words": "生产地址:湖北省宜昌开发区大连路19号"}, {"probability": {"variance": 0.001416, "average": 0.974146, "min": 0.867938}, "location": {"width": 127, "top": 1205, "height": 16, "left": 155}, "words": "邮政編码:443005"}, {"probability": {"variance": 0.000348, "average": 0.991773, "min": 0.925344}, "location": {"width": 183, "top": 1224, "height": 17, "left": 155}, "words": "电话号码:0717-6345005"}, {"probability": {"variance": 0.007547, "average": 0.961235, "min": 0.644677}, "location": {"width": 164, "top": 1244, "height": 17, "left": 229}, "words": "0717-6345093(销售"}, {"probability": {"variance": 0.00207, "average": 0.971195, "min": 0.821564}, "location": {"width": 164, "top": 1263, "height": 18, "left": 229}, "words": "0717-6343387(质量"}, {"probability": {"variance": 0.000225, "average": 0.991986, "min": 0.95047}, "location": {"width": 183, "top": 1280, "height": 17, "left": 154}, "words": "传真号码:0717-6345002"}, {"probability": {"variance": 0.002286, "average": 0.974913, "min": 0.867073}, "location": {"width": 335, "top": 1265, "height": 34, "left": 556}, "words": "宜昌人福药业有限责任公司"}, {"probability": {"variance": 0.023028, "average": 0.852924, "min": 0.506914}, "location": {"width": 267, "top": 1299, "height": 23, "left": 154}, "words": "网址:http:www. yaren. com.cn"}, {"probability": {"variance": 0.001192, "average": 0.865833, "min": 0.830018}, "location": {"width": 330, "top": 1294, "height": 30, "left": 561}, "words": " NICHANG HUMANWELL PHARMACEUTICAL COID"}, {"probability": {"variance": 2.7e-05, "average": 0.997171, "min": 0.982861}, "location": {"width": 210, "top": 1319, "height": 18, "left": 156}, "words": "如有问题可与生产企业直接联系"}], "language": 3}